Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 3/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | IGF2R | P11717 | 4/20 | 0.43 |
| ▸ | SELL | P14151 | 6/20 | 0.43 |
| ▸ | SELP | P16109 | 6/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15618706 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP | |
| SCHEMBL301659 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP | |
| SCHEMBL3176545 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP | |
| SCHEMBL15618707 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP | |
| SCHEMBL15618393 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP | |
| SCHEMBL15618264 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP | |
| SCHEMBL15618678 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP | |
| SCHEMBL13429018 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP | |
| SCHEMBL15628334 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP | |
| SCHEMBL15618676 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180111955-A1 | THIOSACCHARIDE MUCOLYTIC AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180111955-A1 | THIOSACCHARIDE MUCOLYTIC AGENTS | MUC1, TREH, FUT6 | GBA1 161/4885MAPK1 4819/4885IGF2R 1939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.